Liver Diseases  >>  IDX 184  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
IDX 184 / Merck (MSD)
NCT00730431: Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)

Completed
1
48
US
IDX184, Placebo
Merck Sharp & Dohme LLC
Hepatitis C
10/08
10/08
NCT01157104: A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)

Completed
1
20
US
IDX320, IDX184, IDX184 placebo, IDX320 placebo
Merck Sharp & Dohme LLC
Chronic Hepatitis C
07/10
08/10
NCT01335607: A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006)

Completed
1
12
US
Samatasvir tablet, Samatasvir capsule
Merck Sharp & Dohme LLC
Hepatitis C
05/11
05/11

Download Options